Real-time enrollment status for this myelofibrosis clinical trial
Current Status
Unknown
Checked: March 2, 2026 at 10:34 AM UTC
| NCT Number | NCT03662126 |
| Recruiting Status | Unknown |
| Condition | Myelofibrosis |
| Phase | Clinical Trial |
| Target Enrollment | 385 participants |
| Active Locations | 19 sites in the US |
| Sponsor | Kartos Therapeutics, Inc. |
| Last Updated on CT.gov | April 28, 2023 (Apr 28, 2023) |
As of March 2, 2026: Clinical trial NCT03662126 is currently unknown participants. This clinical trial study for myelofibrosis is not currently accepting new participants at 19 locations across the United States. The study is sponsored by Kartos Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT03662126 is currently unknown. The study may resume recruiting in the future.
This trial is recruiting at 19 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03662126 was last updated Apr 28, 2023 (April 28, 2023). HelloStudys verifies this status automatically.